Status:
RECRUITING
Efficacy and Safety of Pulsed Radiofrequency Combined With Platelet Rich Plasma to Treat Idiopathic Glossopharyngeal Neuralgia (GPN)
Lead Sponsor:
Beijing Tiantan Hospital
Collaborating Sponsors:
China-Japan Friendship Hospital
The Second Hospital of Hebei Medical University
Conditions:
Glossopharyngeal Neuralgia
Pulsed Radiofrequency
Eligibility:
All Genders
18+ years
Brief Summary
To investigate the efficacy and safety of the application of PRF combined PRP to the for the treatment of GPN.
Eligibility Criteria
Inclusion
- age \>18 years;
- diagnosed with idiopathic GPN according to the third International Classification of Headache Disorders (ICHD) classification;
- patients who failed pharmacotherapy or intolerable side effects of medication;
- undergoing PRF for GPN;
- at least 1 month of follow-up recordings.
Exclusion
- Patients with bilateral GPN;
- Abnormalities in blood measurements, liver and kidney function, blood glucose, coagulation, electrocardiography or chest radiography;
- Infection at the puncture site;
- Previous mental illness;
- Previous history of narcotic drug abuse;
- Prior anticoagulant or antiplatelet therapy;
- An implantable pulse generator;
- Current pregnancy or breast feeding.
- Patients with incomplete medical records (lack of baseline data or postoperative follow-up data).
Key Trial Info
Start Date :
May 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2027
Estimated Enrollment :
121 Patients enrolled
Trial Details
Trial ID
NCT06931457
Start Date
May 1 2025
End Date
June 1 2027
Last Update
July 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Tiantan Hospital
Beijing, Beijing Municipality, China, 100070